(Q33938119)

30 July 2017

Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans (English)

1 reference

Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.

30 July 2017

Mycobacterium ulcerans

0 references

0 references

0 references

D Ofori-Adjei

8

0 references

Richard Phillips

object named as

R Phillips

6

0 references

author name string

S Etuaful

1

1 reference

30 July 2017

B Carbonnelle

2

1 reference

30 July 2017

J Grosset

3

1 reference

30 July 2017

S Lucas

4

1 reference

30 July 2017

C Horsfield

5

1 reference

30 July 2017

M Evans

7

1 reference

30 July 2017

E Klustse

9

1 reference

30 July 2017

J Owusu-Boateng

10

1 reference

30 July 2017

G K Amedofu

11

1 reference

30 July 2017

P Awuah

12

1 reference

30 July 2017

E Ampadu

13

1 reference

30 July 2017

G Amofah

14

1 reference

30 July 2017

K Asiedu

15

1 reference

30 July 2017

M Wansbrough-Jones

16

1 reference

30 July 2017

Etuaful, S.

0 references

Carbonnelle, B.

0 references

Grosset, J.

0 references

Lucas, S.

0 references

Horsfield, C.

0 references

Phillips, R.

0 references

Evans, M.

0 references

Ofori-Adjei, D.

0 references

Klustse, E.

0 references

Owusu-Boateng, J.et.al.

0 references

language of work or name

English

0 references

publication date

1 August 2005

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

2005

0 references

published in

1 reference

30 July 2017

49

1 reference

30 July 2017

3182-3186

1 reference

30 July 2017

8

1 reference

http://ugspace.ug.edu.gh/handle/123456789/28731

30 July 2017

0 references

cites work

Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Aquatic insects as a vector for Mycobacterium ulcerans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Buruli ulcer in Ghana: results of a national case search

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Activities of several antimicrobials against Mycobacterium ulcerans infection in mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Mycobacterium ulcerans disease; Buruli ulcer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

In vitro susceptibility of Mycobacterium ulcerans to clarithromycin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Activity of rifampicin on Mycobacterium ulcerans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Socioeconomic implications of Buruli ulcer in Ghana: a three-year review

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Epidemiology of Buruli ulcer in Amansie West district, Ghana

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

Cotrimoxazol in the Treatment of Mycobacterium Ulcerans Infection (Buruli Ulcer) in West Africa

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1196249

A pilot study of treatment of Buruli ulcer with rifampin and dapsone

29 October 2018

1 reference

12 December 2020

[Bacteriology and human and experimental pathology of ulcers caused by Mycobacterium ulcerans]

1 reference

12 December 2020

A method for counting acid-fast bacteria

1 reference

12 December 2020

Rifampicin in experimental Mycobacterium ulcerans infection

1 reference

12 December 2020

Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana

1 reference

12 December 2020

10.1128/AAC.49.8.3182-3186.2005

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference